ElevenLabs Launches Eleven Music in Collaboration with Music Industry Partners
5.8.2025 15:52:00 CEST | Business Wire | Press release
New Product Enables Businesses, Creators, Artists, and Everyday Users to Seamlessly Generate Music for Countless Applications
ElevenLabs, the leading AI audio research and product company, today announced the launch of Eleven Music, expanding on its mission to build the most comprehensive AI audio platform in the world. Eleven Music enables businesses, creators, artists, and everyday users to generate studio-grade music from natural language prompts. Eleven Music was built in partnership with artists, labels, and publishers, and includes guardrails to protect rightsholders.
Eleven Music users can effortlessly generate their ideal track, in any genre or style, with or without vocals, in numerous languages – and in a matter of minutes. Generated tracks can be used for nearly any application. ElevenLabs plans to integrate Eleven Music into its full suite of tools, including its Conversational AI platform.
“As an AI audio company, expanding into music was a natural progression, and we are thrilled to introduce Eleven Music today,” said Mati Staniszewski, CEO and Co-Founder of ElevenLabs. “We’ve heard massive demand from our enterprise partners and users for a music model like this and we took our time to ship one that we’re certain they’ll love. We’re proud to do so in collaboration with music industry partners who recognize the vast benefits and possibilities of AI innovation in music.”
ElevenLabs has worked with a range of partners to develop the first Eleven Music model. In addition, ElevenLabs has reached agreements with Merlin – the digital music licensing partner for the world’s leading independent labels and distributors – and Kobalt – the largest independent music publisher in the world. These groundbreaking deals will allow the premier artists and songwriters that Merlin and Kobalt represent to participate in the development of Eleven Music Pro, a subsequent model that the company plans to release in the coming months. The Merlin and Kobalt partnerships will help ElevenLabs continue to deliver the best AI audio tools to its millions of users.
“We are excited to partner with ElevenLabs,” said Jeremy Sirota, CEO of Merlin. “As we navigate the transformative yet challenging opportunities that AI presents, it is core to Merlin’s mission that we work with partners who respect the extraordinary cultural contribution of our members, their artists and their music. We will be very deliberate about who we work with and have been in conversations with many companies in this space. Our partnership with ElevenLabs demonstrates that music rightsholders can negotiate thoughtful, forward-looking agreements with AI companies. Together, we have created responsible guardrails that showcase how AI companies and music rightsholders can collaborate. We look forward to sharing further announcements as we work together towards the launch of Eleven Music Pro.”
Laurent Hubert, CEO of Kobalt said: “Our songwriters and clients entrust us to ensure that the AI revolution includes both strong protections for their intellectual property rights for AI training, as well as forward-looking and thoughtful opportunities to participate in AI revenue streams, subject to clear and fair guardrails. ElevenLabs has been a collaborative partner, committed to sourcing data directly from rightsholders and protecting them. We are excited about this partnership and seeing ElevenLabs become a pioneer in licensing premium music for their Music Pro offering. Kobalt looks forward to working with our songwriters and partners who wish to be part of this opportunity with ElevenLabs.”
Eleven Music is available today on the ElevenLabs website. Outputs are cleared for broad commercial use. For more information on supported usage, please visit elevenlabs.io/music-terms.
About ElevenLabs
Founded in 2022, ElevenLabs is the global leader in AI audio research and technology, building cutting-edge AI audio tools for enterprises, developers, creators, and artists. The platform empowers millions of individuals and thousands of businesses, including employees from over 72% of the Fortune 500, to quickly and affordably create high-quality voice overs at scale, launch interactive AI voice agents in over 30 languages, and now generate studio-quality music.
About Merlin
Merlin is the digital music licensing partner for the world’s leading independent labels and distributors. We’ve negotiated premium deals with Apple, Canva, Meta, Spotify, YouTube, and 40 other innovative platforms around the world. Our global membership is from 70+ countries around the world, representing 15% of the recorded music market. Merlin operates for the benefit of its members, without investors looking for an exit, and is funded entirely by our low 1.5% admin fee. Merlin helps the world’s leading independents to own their digital business through world-class deals and white-glove support.
Find out more at www.merlinnetwork.org.
About Kobalt
Kobalt Music is the leading independent music publishing destination for songwriters and publishers, powered by technology. Across 10 global offices, Kobalt serves over 1 Million songs, representing some of the biggest songwriters in the world. On average, Kobalt represents over 35% of the top 100 songs and albums in the US and the UK. With a relentless focus on advancing the interests of creators, Kobalt leverages cutting-edge technology to streamline the complex processes of music publishing administration. The company’s dedication to transparency, coupled with its forward-thinking approach, has positioned it as a trusted partner for songwriters and rights holders navigating the ever-evolving music industry.
Kobalt’s unwavering commitment to empowering creators and reshaping the future of music rights management solidifies its standing as a global leader in the music industry. The company continues to transform the industry, most recently via AMRA, its global digital music collection society designed to maximize value for songwriters and publishers in today's digital age, while providing the highest level of transparency and efficiency. For more information about Kobalt, please visit www.kobaltmusic.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250805333301/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom